These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Study of a proposed international standard for blood coagulation factor IX. Brozović M, Kirkwood TB, Robertson I. Thromb Haemost; 1976 Feb 29; 35(1):222-36. PubMed ID: 989189 [Abstract] [Full Text] [Related]
3. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent. Mazurier C, Parquet-Gernez A, Goudemand M. Thromb Haemost; 1990 Oct 22; 64(2):251-5. PubMed ID: 2125374 [Abstract] [Full Text] [Related]
4. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta. Meager A, Das RG. J Immunol Methods; 2005 Nov 30; 306(1-2):1-15. PubMed ID: 16226271 [Abstract] [Full Text] [Related]
9. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2. Dodt J, Costanzo A, Daas A, Hunfeld A, Buchheit KH. Pharmeur Bio Sci Notes; 2010 Apr 30; 2010(1):31-8. PubMed ID: 20223188 [Abstract] [Full Text] [Related]
10. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH. Kasper CK, Aronson DL, Davignon G, Foster P, Hillman-Wiseman C, Lusher JM, Manco-Johnson M, Meade JB, Montgomery RR, Rickles FR. Thromb Haemost; 1995 Sep 30; 74(3):987-9. PubMed ID: 8571334 [Abstract] [Full Text] [Related]
11. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group. White GC, Shapiro AD, Kurczynski EM, Kim HC, Bergman GE. Thromb Haemost; 1995 May 30; 73(5):779-84. PubMed ID: 7482403 [Abstract] [Full Text] [Related]
12. Performances of an artificial reagent for the one-stage factor IX assay. Meunier L, Allain JP, Frommel D. Thromb Diath Haemorrh; 1975 Jun 30; 33(3):547-52. PubMed ID: 1154311 [Abstract] [Full Text] [Related]
14. A collaborative study to establish a Korean Standard for factor VIII:C concentrate. Kang HN, Kim SN, Lee SH, Hong SH. Thromb Res; 2004 Jun 30; 113(3-4):261-7. PubMed ID: 15140591 [Abstract] [Full Text] [Related]
16. [Effect of substrate and diluent for factor VIII activity in highly purified factor VIII concentrate and patient plasma infused factor VIII concentrate]. Takahashi I, Furuta M, Mizuno S, Takamatsu J, Kamiya T. Rinsho Byori; 1993 Jul 30; 41(7):825-30. PubMed ID: 8361054 [Abstract] [Full Text] [Related]
17. The abnormal factor IX of hemophilia B+ variants. Bertina RM, Veltkamp JJ. Thromb Haemost; 1978 Oct 31; 40(2):335-49. PubMed ID: 734633 [Abstract] [Full Text] [Related]
18. Biochemical and in vivo properties of high purity factor IX concentrates. Berntorp E, Björkman S, Carlsson M, Lethagen S, Nilsson IM. Thromb Haemost; 1993 Nov 15; 70(5):768-73. PubMed ID: 8128433 [Abstract] [Full Text] [Related]
19. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery. Santagostino E, Mannucci PM, Gringeri A, Tagariello G, Baudo F, Bauer KA, Rosenberg RD. Thromb Haemost; 1994 Jun 15; 71(6):737-40. PubMed ID: 7974341 [Abstract] [Full Text] [Related]
20. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B. Orstavik KH, Scheibel E, Ingerslev J, Schwartz M. Thromb Haemost; 2000 Mar 15; 83(3):433-7. PubMed ID: 10744150 [Abstract] [Full Text] [Related] Page: [Next] [New Search]